Radnet
Open
$56.39
Prev. Close
$56.32
High
$56.72
Low
$56.34
Market Snapshot
$4.39B
-309.0
0.04
$1.83B
RadNet, Inc. provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. The company is headquartered in Los Angeles, California and currently employs 8,844 full-time employees. The company went IPO on 2001-12-12. The firm has a network of 407 owned and/or operated outpatient imaging centers. Its Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Its services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. Its Digital Health segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. The company provides radiology information technology and artificial intelligence (AI) solutions marketed under the DeepHealth brand and teleradiology professional services. The company is also a provider of AI-powered breast health solutions.
RadNet, Inc. provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. The company is headquartered in Los Angeles, California and currently employs 8,844 full-time employees. The company went IPO on 2001-12-12. The firm has a network of 407 owned and/or operated outpatient imaging centers. Its Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Its services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. Its Digital Health segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. The company provides radiology information technology and artificial intelligence (AI) solutions marketed under the DeepHealth brand and teleradiology professional services. The company is also a provider of AI-powered breast health solutions.
Recently from Cashu
RadNet Launches AI-Powered Reporting Pro, Enhancing Imaging Services and Financial Growth Strategy
RadNet (Ticker: RDNT) makes a notable advancement in its healthcare strategy with the recent launch of Reporting Pro, an innovative AI-powered radiology reporting platform that aims to transform the d…
RadNet Secures $200 Million Loan for Growth Amid Profitability Challenges
In early June 2026, RadNet, Inc. (Ticker: RDNT) announces it has secured a US$200 million incremental term loan, aimed at bolstering its acquisition strategies and enhancing its imaging network. This…
RadNet Expands Outpatient Imaging Services Through New Joint Venture and Community Initiatives
RadNet is making significant strides in the healthcare sector, especially in outpatient diagnostic imaging services. The company recently takes a bold step by launching a joint venture with Saint Alph…
Radnet Leads in Advancements of Cardiac Imaging Technology with VentriPoint Partnership
Radnet Focuses on Advancements in Cardiac Imaging Technology Radnet, a leader in the medical imaging industry, is on the brink of significant developments in cardiac care enhancement through innovativ…